NCT00223457View on ClinicalTrials.gov

Factors That Influence Compliance With Disease-Modifying Therapy in Multiple Sclerosis

CompletedOBSERVATIONAL

Enrollment

1,040

Participants

Timeline

Start Date

April 30, 2004

Study Completion Date

September 30, 2005

Conditions

Multiple Sclerosis

Interventions

BEHAVIORAL

Factors that influence compliance

Trial Locations (1)

75390

UT Southwestern Medical Center, Dallas

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Biogen

INDUSTRY

lead

University of Texas Southwestern Medical Center

OTHER